MedEsthetics
FEBRUARY 20, 2024
The American Academy of Dermatology made strong recommendations for topical benzoyl peroxide, retinoids, and/or antibiotics and their fixed-dose combinations and for oral doxycycline.
Dermatology Times
FEBRUARY 20, 2024
Researchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedEsthetics
FEBRUARY 20, 2024
In our Movers & Shakers industry news roundup, PatientNow enhances its digital practice management solution, Empower Aesthetics adds to its brand portfolios and CoValence Laboratories celebrates 35 years.
Dermatology Times
FEBRUARY 20, 2024
IV antibiotics should play a complementary role in the management of HS as new immunomodulator therapies are developed, researchers concluded.
CAMEO College - Esthetics
FEBRUARY 20, 2024
Botox, often associated with cosmetic treatments for wrinkles and fine lines, actually offers a multitude of hidden benefits that go. The post The Secret Benefits of Botox: Dermatology Insights first appeared on Cameo College of Essential Beauty.
Dermatology Times
FEBRUARY 20, 2024
This week’s collection of the latest dermatologic studies covers hair matrix cells, comorbidity associations of hidradenitis suppurativa, risk factors of infantile hemangioma, and giant cell collagenomas in a patient with Cowden syndrome.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
FEBRUARY 20, 2024
Explore Dermatology Times' coverage of the 2024 Masterclasses in Dermatology conference on topics ranging from artificial intelligence lessons from GI to cardiovascular considerations in psoriasis treatment.
The Dermatology Digest
FEBRUARY 20, 2024
A new biosensor using terahertz (THz) waves can detect skin cancer with “exceptional” sensitivity, potentially paving the way for earlier and easier diagnoses, according to a study in the IEEE Transactions on Biomedical Engineering. “Traditional methods for detecting skin cancer often involve expensive, time-consuming, CT, PET scans and invasive higher frequencies technologies,” explains study author Shohreh Nourinovin, PhD, Postdoctoral Research Associate at Queen Mary’s Schoo
Dermatology Times
FEBRUARY 20, 2024
Officials recently reported the first known fatality from the virus. Here's what health professionals say to watch for.
Beauty Launchpad
FEBRUARY 20, 2024
ARETÉ, the latest entrant into the professional beauty industry, proudly unveils its new collection of consciously crafted hair color, care, treatments and styling products.
Dermatology Times
FEBRUARY 20, 2024
Barbieri spoke with Dermatology Times to discuss the new guidelines and the recommendations and good practice statements included.
The Dermatology Digest
FEBRUARY 20, 2024
The U.S Food and Drug Administration (FDA) has approved lifileucel (Amtagvi, Iovance Biotherapeutics Inc) for advanced melanoma. Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. Iovance also announced the pricing of a secondary stock offering, which when combined with the approval, led to a huge stock gain. “The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T cell immunotherapy
Salon Today
FEBRUARY 20, 2024
Check out the artists and brands that will be featured at SalonCentric's first Pro Beauty Experience in Nashville this March.
AAFE - American Academy of Facial Esthetics
FEBRUARY 20, 2024
By Katie Barrer, RDH Who better suited to treat their patients for bruxism than dental hygienists? Two states allow RDHs to administer Botox for bruxism. Here’s what you need to know. Kansas was the first state to pass legislation allowing registered dental hygienists to administer neurotoxin, commonly known as Botox, in 2022. Neighboring state Oklahoma followed soon after.
Salon Today
FEBRUARY 20, 2024
Introducing Cécred, a haircare brand founded by Beyoncé Knowles-Carter, launching in tandem with the Cécred x BeyGOOD Fund, awarding an annual $500,000 to fund cosmetology school scholarships and salon business grants across 5 cities chosen for their large, diverse community of hairstylists.
Artemis
FEBRUARY 20, 2024
While good nutrition and exercise are key to a great physique, they sometimes don’t hit the mark on stubborn areas. That’s where the magic of non-invasive body contouring treatments comes into play, offering a solution without the need for surgery.
Spa Industry Association
FEBRUARY 20, 2024
ZERO-WASTE SPA SLIDES ARE POSSIBLE… AND WE MADE IT EASIER THAN EVER From Feelgoodz click here to see more – Continue reading Sustainable Spa Slides from Feelgoodz at Spa Industry Association.
Skin Inc
FEBRUARY 20, 2024
The American Academy of Dermatology made strong recommendations for topical benzoyl peroxide, retinoids, and/or antibiotics and their fixed-dose combinations and for oral doxycycline.
Spa Industry Association
FEBRUARY 20, 2024
hese days, Botox treatment is one of the most popular ones in the sphere of aesthetic medicine. With its help, thousands of people worldwide effectively take care of a wide range of health and cosmetic issues related to muscle contraction. But who is legally allowed to purchase Botox? Do you need to have a special license to order it? And does it belong to products intended for professional use?
Beauty Launchpad
FEBRUARY 20, 2024
Cécred launches with the debut of the Foundation Collection featuring eight products that cleanse, condition and visibly repair.
Skin Inc
FEBRUARY 20, 2024
With the Face & Body show coming up we will have a myriad of educational opportunities. But, we want to know what topics you're most interested in.
Beauty Launchpad
FEBRUARY 20, 2024
ARETÉ, the latest entrant into the professional beauty industry, proudly unveils its new collection of consciously crafted hair color, care, treatments and styling products.
The Dermatology Digest
FEBRUARY 20, 2024
The U.S Food and Drug Administration (FDA) has approved lifileucel (Amtagvi, Iovance Biotherapeutics Inc) for advanced melanoma. Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. Iovance also announced the pricing of a secondary stock offering, which when combined with the approval, led to a huge stock gain. “The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T cell immunotherapy
Aesthetics Advisor
FEBRUARY 20, 2024
Collagen—a sort of natural glue for the skin—diminishes as we age, however, supplementation may help to support aging skin and joints. Collagen, once a buzzword mostly heard in beauty circles, is now gaining wider recognition for its health benefits, propelled by a flurry of scientific research and discoveries. Collagen peptides, the building blocks of this essential protein, are increasingly sought for their potential health benefits, ranging from skin rejuvenation to muscle strengthening.
The Dermatology Digest
FEBRUARY 20, 2024
A new biosensor using terahertz (THz) waves can detect skin cancer with “exceptional” sensitivity, potentially paving the way for earlier and easier diagnoses, according to a study in the IEEE Transactions on Biomedical Engineering. “Traditional methods for detecting skin cancer often involve expensive, time-consuming, CT, PET scans and invasive higher frequencies technologies,” explains study author Shohreh Nourinovin, PhD, Postdoctoral Research Associate at Queen Mary’s Schoo
West Lake Dermatology
FEBRUARY 20, 2024
Botox has long reigned as the gold standard for reducing wrinkles and fine lines. Its ability to deliver quick, noticeable results by temporarily paralyzing muscles has made it a favorite among patients seeking to rejuvenate their appearance. However, as the demand for non-invasive treatments continues to rise, so does the quest for alternatives to Botox that offer comparable or even superior results.
The Dermatology Digest
FEBRUARY 20, 2024
Starting with splashy purple-themed debut at IMCAS in Paris and followed by an educational media event in New York City, La Roche-Posay has officially launched MelaB3 Serum & MelaB3 UV. Formulated with Melasyl pigment inhibitor/blocker, L’Oreal’s new multi-patented molecule designed to improve the appearance of dark spots and discoloration, plus 10% niacinamide, MelaB3 Serum reduces a range of skin discoloration on all skin tones, including sunspots, age spots, post-acne marks (or post
Dermatology Times
FEBRUARY 20, 2024
Mark Lebwohl, MD, introduces a video program providing a comprehensive year in review regarding the management of plaque psoriasis, highlighting key therapeutic approvals from 2023. The discussion will highlight pivotal clinical studies supporting these approvals and our discussion will then pivot to have a special focus on addressing the unique challenges faced by treating patients with skin of color and treatment access barriers.
The Dermatology Digest
FEBRUARY 20, 2024
Starting with splashy purple-themed debut at IMCAS in Paris and followed by an educational media event in New York City, La Roche-Posay has officially launched MelaB3 Serum & MelaB3 UV. Formulated with Melasyl pigment inhibitor/blocker, L’Oreal’s new multi-patented molecule designed to improve the appearance of dark spots and discoloration, plus 10% niacinamide, MelaB3 Serum reduces a range of skin discoloration on all skin tones, including sunspots, age spots, post-acne marks (or post
The Dermatology Digest
FEBRUARY 20, 2024
Beiersdorf’s Residents of Distinction program mentor and former mentee Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, chats with his mentee Dawn Queen, MD, a Resident at Columbia University Irving Medical Center in New York City, about her experience as one of this year’s five Beiersdorf dermatology Residents of Distinction.
The Dermatology Digest
FEBRUARY 20, 2024
Biofrontera has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors. The Company raised financing of $8M with an additional $8M tied to milestones for aggregate proceeds of $16M gross priced at market per Nasdaq rules. The stock soared with the announcement, according to media reports.
The Dermatology Digest
FEBRUARY 20, 2024
Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc. In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I am thrilled to be taking on a more formal role at Obagi as the Company’s first-ever Chief Medical Director,” says Dr.
The Dermatology Digest
FEBRUARY 20, 2024
Beiersdorf’s Residents of Distinction program mentor and former mentee Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, chats with his mentee Dawn Queen, MD, a Resident at Columbia University Irving Medical Center in New York City, about her experience as one of this year’s five Beiersdorf dermatology Residents of Distinction.
Expert insights. Personalized for you.
148 
Let's personalize your content